Hahn Capital Management’s Bio-Techne TECH Stock Holding History

Hahn Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.59M	Sell	50,766 -1,466	-3%	-$79.2K	2.17%	23
2026 Q1	$2.73M	Sell	52,232 -7,810	-13%	-$469K	1.72%	25
2025 Q4	$3.53M	Sell	60,042 -4,696	-7%	-$285K	1.9%	26
2025 Q3	$3.6M	Sell	64,738 -2,821	-4%	-$151K	1.73%	25
2025 Q2	$3.48M	Sell	67,559 -930	-1%	-$46.7K	1.64%	25
2025 Q1	$4.02M	Sell	68,489 -6,074	-8%	-$412K	1.94%	25
2024 Q4	$5.37M	Buy	74,563 +29,854	+67%	+$2.19M	2.35%	23
2024 Q3	$3.57M	Sell	44,709 -21,302	-32%	-$1.6M	2.3%	23
2024 Q2	$4.73M	Buy	66,011 +15,216	+30%	+$1.12M	2.25%	24
2024 Q1	$3.58M	Buy	+50,795	New	+$3.63M	2.14%	23

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hahn Capital Management's TECH Position: Q2 2026 in Review

Hahn Capital Management reduced its Bio-Techne (TECH) stake by 2.8% in Q2 2026, selling an estimated $79.2K and leaving 50,766 shares worth $3.59M. The position accounts for 2.17% of the portfolio, ranked #23.

Hahn Capital Management first reported a position in TECH in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.37M in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Hahn Capital Management held 50,766 shares of Bio-Techne worth $3.59M as of Q2 2026.
Hahn Capital Management sold 1,466 Bio-Techne shares in Q2 2026, an estimated $79.2K.
Bio-Techne made up 2.17% of Hahn Capital Management's portfolio in Q2 2026, its #23 holding.
Hahn Capital Management first reported a position in Bio-Techne in Q1 2024 and has held it in 10 quarters since.
Hahn Capital Management's Bio-Techne position peaked at $5.37M in Q4 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Hahn Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.